Despite rapid advances in automation and AI, I believe humans will remain central to manufacturing success in 2026.
Continue reading to explore the role of automation in semiconductor manufacturing, as well as its challenges, advantages, and future directions. Like in many industries, automation came in ...
For many decades, businesses have focused their manufacturing operations in faraway production locations where labor and shipping costs are traditionally more affordable. However, recent global ...
Process manufacturing is extremely complex. Operating in a manner that ensures safety, reliability, efficiency and sustainability requires precise orchestration of equipment, people and data to ensure ...
Artificial intelligence (AI) is changing the world and improving our lives in many ways. The semiconductor industry is a key part of the AI revolution, as it provides powerful computing chips for AI ...
As AI continues to evolve, its capacity to innovate and optimize will further solidify its role as a cornerstone of modern ...
FOYE recognizes that advancing industrial automation does not mean replacing pneumatic technology, but elevating it. By improving precision, standardization, and compatibility, pneumatic components ...
Nestlé transformed a critical powder production process from manual guesswork requiring decades of experience to an automated system that new workers can master within a couple of years. Discover the ...
The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...
Airborne, a leader in automation and digitalization of composite manufacturing processes, and FIDAMC (Foundation for Research, Development, and Application of Composite Materials), a prominent ...
Patented multi-blade technology and parallel high-speed transport systems ensure precision, reliability and high-volume razor ...
Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...